AK-antiVEGF

N/A

Report date: 2023/10/26 16:52:37

Base Information

Drug NameAK-antiVEGF
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transferenceVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factor
Therapy Area/IndicationsNeurilemmoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAkouos Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyAkouos Inc
Inactive CompaniesN/A
Active IndicationsNeurilemmoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A